_id
691728443c536f8df2316c80
Ticker
VERA
Name
Vera Therapeutics Inc
Exchange
NASDAQ
Address
2000 Sierra Point Parkway, Brisbane, CA, United States, 94005
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://veratx.com
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases. The company's lead product candidate consists of atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN). It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Last Close
46.02
Volume
160105
Current Price
49.8
Change
8.213820078226844
Last Updated
2025-12-04T14:59:25.081Z
Image
https://logo.clearbit.com/veratx.com
Ipo Date
2021-05-14T00:00:00.000Z
Market Cap
2637671936
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9219583333333333
Sentiment Sources
24
Rating
4.5714
Target Price
62.8462
Strong Buy
9
Buy
4
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
564000
Gross Profit
-564000
Operating Expenses
83368000
Operating Income
-83932000
Interest Expense
1960000
Pretax Income
-80293000
Net Income
-80293000
Eps
-1.2575834547106362
Dividends Per Share
-
Shares Outstanding
63928066
Income Tax Expense
-
EBITDA
-77769000
Operating Margin
-
Total Other Income Expense Net
3639000
Cash
57773000
Short Term Investments
439616000
Receivables
3357000
Inventories
-
Total Current Assets
506231000
Property Plant Equipment
3191000
Total Assets
517503000
Payables
17950000
Short Term Debt
473000
Long Term Debt
74648000
Total Liabilities
118623000
Equity
398880000
Depreciation
129000
Change In Working Capital
8686000
Cash From Operations
-61906000
Capital Expenditures
133000
Cash From Investing
69761000
Cash From Financing
797000
Net Change In Cash
8652000
PE
-
PB
7.971277925691937
ROE
-20.129612916165264
ROA
-15.515465610827379
FCF
-62039000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
564000
Quarters > 0 > income Statement > gross Profit
-564000
Quarters > 0 > income Statement > operating Expenses
83368000
Quarters > 0 > income Statement > operating Income
-83932000
Quarters > 0 > income Statement > interest Expense
1960000
Quarters > 0 > income Statement > pretax Income
-80293000
Quarters > 0 > income Statement > net Income
-80293000
Quarters > 0 > income Statement > eps
-1.2575834547106362
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
63847055
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-77769000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
3639000
Quarters > 0 > balance Sheet > cash
57773000
Quarters > 0 > balance Sheet > short Term Investments
439616000
Quarters > 0 > balance Sheet > receivables
3357000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
506231000
Quarters > 0 > balance Sheet > property Plant Equipment
3191000
Quarters > 0 > balance Sheet > total Assets
517503000
Quarters > 0 > balance Sheet > payables
17950000
Quarters > 0 > balance Sheet > short Term Debt
473000
Quarters > 0 > balance Sheet > long Term Debt
74648000
Quarters > 0 > balance Sheet > total Liabilities
118623000
Quarters > 0 > balance Sheet > equity
398880000
Quarters > 0 > cash Flow > net Income
-80293000
Quarters > 0 > cash Flow > depreciation
129000
Quarters > 0 > cash Flow > change In Working Capital
8686000
Quarters > 0 > cash Flow > cash From Operations
-61906000
Quarters > 0 > cash Flow > capital Expenditures
133000
Quarters > 0 > cash Flow > cash From Investing
69761000
Quarters > 0 > cash Flow > cash From Financing
797000
Quarters > 0 > cash Flow > net Change In Cash
8652000
Quarters > 0 > ratios > PE
-1.2575834547106362
Quarters > 0 > ratios > PB
7.971277925691937
Quarters > 0 > ratios > ROE
-20.129612916165264
Quarters > 0 > ratios > ROA
-15.515465610827379
Quarters > 0 > ratios > FCF
-62039000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
563000
Quarters > 1 > income Statement > gross Profit
-563000
Quarters > 1 > income Statement > operating Expenses
79578000
Quarters > 1 > income Statement > operating Income
-80141000
Quarters > 1 > income Statement > interest Expense
1874000
Quarters > 1 > income Statement > pretax Income
-76531000
Quarters > 1 > income Statement > net Income
-76531000
Quarters > 1 > income Statement > eps
-1.1997466095530156
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
63789303
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-74094000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
3610000
Quarters > 1 > balance Sheet > cash
49121000
Quarters > 1 > balance Sheet > short Term Investments
507706000
Quarters > 1 > balance Sheet > receivables
4202000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
571354000
Quarters > 1 > balance Sheet > property Plant Equipment
3622000
Quarters > 1 > balance Sheet > total Assets
578528000
Quarters > 1 > balance Sheet > payables
13157000
Quarters > 1 > balance Sheet > short Term Debt
855000
Quarters > 1 > balance Sheet > long Term Debt
74464000
Quarters > 1 > balance Sheet > total Liabilities
110251000
Quarters > 1 > balance Sheet > equity
468277000
Quarters > 1 > cash Flow > net Income
-76531000
Quarters > 1 > cash Flow > depreciation
119000
Quarters > 1 > cash Flow > change In Working Capital
13382000
Quarters > 1 > cash Flow > cash From Operations
-54798000
Quarters > 1 > cash Flow > capital Expenditures
208000
Quarters > 1 > cash Flow > cash From Investing
28544000
Quarters > 1 > cash Flow > cash From Financing
20285000
Quarters > 1 > cash Flow > net Change In Cash
-5969000
Quarters > 1 > ratios > PE
-1.1997466095530156
Quarters > 1 > ratios > PB
6.78382087824087
Quarters > 1 > ratios > ROE
-16.343104615430608
Quarters > 1 > ratios > ROA
-13.228573206482661
Quarters > 1 > ratios > FCF
-55006000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
57194000
Quarters > 2 > income Statement > operating Income
-57194000
Quarters > 2 > income Statement > interest Expense
1792000
Quarters > 2 > income Statement > pretax Income
-51694000
Quarters > 2 > income Statement > net Income
-51694000
Quarters > 2 > income Statement > eps
-0.811885269086709
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
63671558
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-49817000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
5500000
Quarters > 2 > balance Sheet > cash
55090000
Quarters > 2 > balance Sheet > short Term Investments
534744000
Quarters > 2 > balance Sheet > receivables
3586000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
606076000
Quarters > 2 > balance Sheet > property Plant Equipment
3977000
Quarters > 2 > balance Sheet > total Assets
610167000
Quarters > 2 > balance Sheet > payables
9262000
Quarters > 2 > balance Sheet > short Term Debt
1191000
Quarters > 2 > balance Sheet > long Term Debt
50908000
Quarters > 2 > balance Sheet > total Liabilities
75168000
Quarters > 2 > balance Sheet > equity
534999000
Quarters > 2 > cash Flow > net Income
-51694000
Quarters > 2 > cash Flow > depreciation
85000
Quarters > 2 > cash Flow > change In Working Capital
-9438000
Quarters > 2 > cash Flow > cash From Operations
-54406000
Quarters > 2 > cash Flow > capital Expenditures
187000
Quarters > 2 > cash Flow > cash From Investing
15317000
Quarters > 2 > cash Flow > cash From Financing
1533000
Quarters > 2 > cash Flow > net Change In Cash
-37556000
Quarters > 2 > ratios > PE
-0.811885269086709
Quarters > 2 > ratios > PB
5.926821523778549
Quarters > 2 > ratios > ROE
-9.662447967192463
Quarters > 2 > ratios > ROA
-8.472106816658389
Quarters > 2 > ratios > FCF
-54593000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
48914000
Quarters > 3 > income Statement > operating Income
-48914000
Quarters > 3 > income Statement > interest Expense
1871000
Quarters > 3 > income Statement > pretax Income
-43424000
Quarters > 3 > income Statement > net Income
-43425000
Quarters > 3 > income Statement > eps
-0.7910081436588097
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
54898297
Quarters > 3 > income Statement > income Tax Expense
1000
Quarters > 3 > income Statement > EBITDA
-41498000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
5490000
Quarters > 3 > balance Sheet > cash
92646000
Quarters > 3 > balance Sheet > short Term Investments
548206000
Quarters > 3 > balance Sheet > receivables
3773000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
651218000
Quarters > 3 > balance Sheet > property Plant Equipment
4332000
Quarters > 3 > balance Sheet > total Assets
655681000
Quarters > 3 > balance Sheet > payables
7665000
Quarters > 3 > balance Sheet > short Term Debt
1483000
Quarters > 3 > balance Sheet > long Term Debt
50687000
Quarters > 3 > balance Sheet > total Liabilities
78526000
Quarters > 3 > balance Sheet > equity
577155000
Quarters > 3 > cash Flow > net Income
-43425000
Quarters > 3 > cash Flow > depreciation
55000
Quarters > 3 > cash Flow > change In Working Capital
-728000
Quarters > 3 > cash Flow > cash From Operations
-39182000
Quarters > 3 > cash Flow > capital Expenditures
645000
Quarters > 3 > cash Flow > cash From Investing
-221383000
Quarters > 3 > cash Flow > cash From Financing
325955000
Quarters > 3 > cash Flow > net Change In Cash
65390000
Quarters > 3 > ratios > PE
-0.7910081436588097
Quarters > 3 > ratios > PB
4.736916756503885
Quarters > 3 > ratios > ROE
-7.523975361904514
Quarters > 3 > ratios > ROA
-6.62288521399888
Quarters > 3 > ratios > FCF
-39827000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2169000
Annuals > 0 > income Statement > gross Profit
-2169000
Annuals > 0 > income Statement > operating Expenses
167170000
Annuals > 0 > income Statement > operating Income
-167170000
Annuals > 0 > income Statement > interest Expense
7626000
Annuals > 0 > income Statement > pretax Income
-152147000
Annuals > 0 > income Statement > net Income
-152148000
Annuals > 0 > income Statement > eps
-2.7499933124488947
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
55326680
Annuals > 0 > income Statement > income Tax Expense
1000
Annuals > 0 > income Statement > EBITDA
-144416000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
15023000
Annuals > 0 > balance Sheet > cash
92646000
Annuals > 0 > balance Sheet > short Term Investments
548206000
Annuals > 0 > balance Sheet > receivables
3773000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
651218000
Annuals > 0 > balance Sheet > property Plant Equipment
4332000
Annuals > 0 > balance Sheet > total Assets
655681000
Annuals > 0 > balance Sheet > payables
7665000
Annuals > 0 > balance Sheet > short Term Debt
1483000
Annuals > 0 > balance Sheet > long Term Debt
50687000
Annuals > 0 > balance Sheet > total Liabilities
78526000
Annuals > 0 > balance Sheet > equity
577155000
Annuals > 0 > cash Flow > net Income
-152148000
Annuals > 0 > cash Flow > depreciation
105000
Annuals > 0 > cash Flow > change In Working Capital
2660000
Annuals > 0 > cash Flow > cash From Operations
-134679000
Annuals > 0 > cash Flow > capital Expenditures
972000
Annuals > 0 > cash Flow > cash From Investing
-425029000
Annuals > 0 > cash Flow > cash From Financing
606673000
Annuals > 0 > cash Flow > net Change In Cash
46965000
Annuals > 0 > ratios > PE
-2.7499933124488947
Annuals > 0 > ratios > PB
3.916882197676534
Annuals > 0 > ratios > ROE
-26.361722587519814
Annuals > 0 > ratios > ROA
-23.204576615762846
Annuals > 0 > ratios > FCF
-135651000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1862000
Annuals > 1 > income Statement > cost Of Revenue
-1862000
Annuals > 1 > income Statement > gross Profit
1862000
Annuals > 1 > income Statement > operating Expenses
102012000
Annuals > 1 > income Statement > operating Income
-102012000
Annuals > 1 > income Statement > interest Expense
3786000
Annuals > 1 > income Statement > pretax Income
-95989000
Annuals > 1 > income Statement > net Income
-95990000
Annuals > 1 > income Statement > eps
-2.247637112654316
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
42707072
Annuals > 1 > income Statement > income Tax Expense
1000
Annuals > 1 > income Statement > EBITDA
-92182000
Annuals > 1 > income Statement > operating Margin
-5478.625134264233
Annuals > 1 > income Statement > total Other Income Expense Net
6023000
Annuals > 1 > balance Sheet > cash
45681000
Annuals > 1 > balance Sheet > short Term Investments
115035000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
172023000
Annuals > 1 > balance Sheet > property Plant Equipment
3041000
Annuals > 1 > balance Sheet > total Assets
175546000
Annuals > 1 > balance Sheet > payables
11118000
Annuals > 1 > balance Sheet > short Term Debt
2436000
Annuals > 1 > balance Sheet > long Term Debt
49877000
Annuals > 1 > balance Sheet > total Liabilities
73861000
Annuals > 1 > balance Sheet > equity
101685000
Annuals > 1 > cash Flow > net Income
-95990000
Annuals > 1 > cash Flow > depreciation
-4086000
Annuals > 1 > cash Flow > change In Working Capital
-5869000
Annuals > 1 > cash Flow > cash From Operations
-92181000
Annuals > 1 > cash Flow > capital Expenditures
63000
Annuals > 1 > cash Flow > cash From Investing
-39431000
Annuals > 1 > cash Flow > cash From Financing
133541000
Annuals > 1 > cash Flow > net Change In Cash
1929000
Annuals > 1 > ratios > PE
-2.247637112654316
Annuals > 1 > ratios > PB
17.160947651276
Annuals > 1 > ratios > ROE
-94.39937060530067
Annuals > 1 > ratios > ROA
-54.68082439930275
Annuals > 1 > ratios > FCF
-92244000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-49.54027926960258
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-846000
Annuals > 2 > income Statement > gross Profit
846000
Annuals > 2 > income Statement > operating Expenses
90903000
Annuals > 2 > income Statement > operating Income
-90903000
Annuals > 2 > income Statement > interest Expense
992000
Annuals > 2 > income Statement > pretax Income
-89055000
Annuals > 2 > income Statement > net Income
-89056000
Annuals > 2 > income Statement > eps
-3.351664820270286
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
26570676
Annuals > 2 > income Statement > income Tax Expense
1000
Annuals > 2 > income Statement > EBITDA
-91749000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1848000
Annuals > 2 > balance Sheet > cash
43459000
Annuals > 2 > balance Sheet > short Term Investments
71194000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
125698000
Annuals > 2 > balance Sheet > property Plant Equipment
5224000
Annuals > 2 > balance Sheet > total Assets
131435000
Annuals > 2 > balance Sheet > payables
11991000
Annuals > 2 > balance Sheet > short Term Debt
2645000
Annuals > 2 > balance Sheet > long Term Debt
24810000
Annuals > 2 > balance Sheet > total Liabilities
54527000
Annuals > 2 > balance Sheet > equity
76908000
Annuals > 2 > cash Flow > net Income
-89056000
Annuals > 2 > cash Flow > depreciation
-846000
Annuals > 2 > cash Flow > change In Working Capital
6747000
Annuals > 2 > cash Flow > cash From Operations
-67596000
Annuals > 2 > cash Flow > capital Expenditures
62000
Annuals > 2 > cash Flow > cash From Investing
-70552000
Annuals > 2 > cash Flow > cash From Financing
101933000
Annuals > 2 > cash Flow > net Change In Cash
-36215000
Annuals > 2 > ratios > PE
-3.351664820270286
Annuals > 2 > ratios > PB
14.116578527071306
Annuals > 2 > ratios > ROE
-115.79549591719977
Annuals > 2 > ratios > ROA
-67.75668581428083
Annuals > 2 > ratios > FCF
-67658000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
22
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
176000
Annuals > 3 > income Statement > gross Profit
-176000
Annuals > 3 > income Statement > operating Expenses
34402000
Annuals > 3 > income Statement > operating Income
-34402000
Annuals > 3 > income Statement > interest Expense
20000
Annuals > 3 > income Statement > pretax Income
-32608000
Annuals > 3 > income Statement > net Income
-32609000
Annuals > 3 > income Statement > eps
-2.4270403058834424
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
13435706
Annuals > 3 > income Statement > income Tax Expense
1000
Annuals > 3 > income Statement > EBITDA
-34226000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
1794000
Annuals > 3 > balance Sheet > cash
79674000
Annuals > 3 > balance Sheet > short Term Investments
867000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
82537000
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
83748000
Annuals > 3 > balance Sheet > payables
1385000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
4923000
Annuals > 3 > balance Sheet > total Liabilities
14156000
Annuals > 3 > balance Sheet > equity
69592000
Annuals > 3 > cash Flow > net Income
-32609000
Annuals > 3 > cash Flow > depreciation
176000
Annuals > 3 > cash Flow > change In Working Capital
3511000
Annuals > 3 > cash Flow > cash From Operations
-23708000
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-4204000
Annuals > 3 > cash Flow > cash From Financing
53882000
Annuals > 3 > cash Flow > net Change In Cash
25970000
Annuals > 3 > ratios > PE
-2.4270403058834424
Annuals > 3 > ratios > PB
7.888592757213473
Annuals > 3 > ratios > ROE
-46.85739740200023
Annuals > 3 > ratios > ROA
-38.937049242967
Annuals > 3 > ratios > FCF
-23708000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-1.2575834547106362
Valuation > metrics > PB
7.971277925691937
Valuation > final Score
20
Valuation > verdict
165.7% Overvalued
Profitability > metrics > ROE
-20.129612916165264
Profitability > metrics > ROA
-15.86094095383333
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.29739019253910953
Risk > metrics > Interest Coverage
-42.82244897959184
Risk > final Score
-111
Risk > verdict
High
Liquidity > metrics > Current Ratio
27.4782065895891
Liquidity > metrics > Quick Ratio
27.4782065895891
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20.73178476221451
Prev Valuations > 2
32.63083243496115
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-111
Prev Risks > 1
-68
Prev Risks > 2
-45
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:22:53.282Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-19
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-1.3
Earnings History > 0 > eps Difference
1.3
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-05
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.26
Earnings History > 1 > eps Estimate
-1.15
Earnings History > 1 > eps Difference
-0.11
Earnings History > 1 > surprise Percent
-9.5652
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-05
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.2
Earnings History > 2 > eps Estimate
-0.82
Earnings History > 2 > eps Difference
-0.38
Earnings History > 2 > surprise Percent
-46.3415
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-15
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.8119
Earnings History > 3 > eps Estimate
-0.7795
Earnings History > 3 > eps Difference
-0.0324
Earnings History > 3 > surprise Percent
-4.1565
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.72
Earnings History > 4 > eps Estimate
-0.81
Earnings History > 4 > eps Difference
0.09
Earnings History > 4 > surprise Percent
11.1111
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.85
Earnings History > 5 > eps Estimate
-0.6375
Earnings History > 5 > eps Difference
-0.2125
Earnings History > 5 > surprise Percent
-33.3333
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.62
Earnings History > 6 > eps Estimate
-0.56
Earnings History > 6 > eps Difference
-0.06
Earnings History > 6 > surprise Percent
-10.7143
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.56
Earnings History > 7 > eps Estimate
-0.53
Earnings History > 7 > eps Difference
-0.03
Earnings History > 7 > surprise Percent
-5.6604
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-20
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.6
Earnings History > 8 > eps Estimate
-0.51
Earnings History > 8 > eps Difference
-0.09
Earnings History > 8 > surprise Percent
-17.6471
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.45
Earnings History > 9 > eps Estimate
-0.53
Earnings History > 9 > eps Difference
0.08
Earnings History > 9 > surprise Percent
15.0943
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-10
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.46
Earnings History > 10 > eps Estimate
-0.69
Earnings History > 10 > eps Difference
0.23
Earnings History > 10 > surprise Percent
33.3333
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.8
Earnings History > 11 > eps Estimate
-0.6
Earnings History > 11 > eps Difference
-0.2
Earnings History > 11 > surprise Percent
-33.3333
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-28
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-1.18
Earnings History > 12 > eps Estimate
-0.9
Earnings History > 12 > eps Difference
-0.28
Earnings History > 12 > surprise Percent
-31.1111
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.91
Earnings History > 13 > eps Estimate
-0.72
Earnings History > 13 > eps Difference
-0.19
Earnings History > 13 > surprise Percent
-26.3889
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-10
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.55
Earnings History > 14 > eps Estimate
-0.72
Earnings History > 14 > eps Difference
0.17
Earnings History > 14 > surprise Percent
23.6111
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-16
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.71
Earnings History > 15 > eps Estimate
-0.67
Earnings History > 15 > eps Difference
-0.04
Earnings History > 15 > surprise Percent
-5.9701
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-24
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.79
Earnings History > 16 > eps Estimate
-0.46
Earnings History > 16 > eps Difference
-0.33
Earnings History > 16 > surprise Percent
-71.7391
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.36
Earnings History > 17 > eps Estimate
-0.59
Earnings History > 17 > eps Difference
0.23
Earnings History > 17 > surprise Percent
38.9831
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-16
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.33
Earnings History > 18 > eps Estimate
-0.39
Earnings History > 18 > eps Difference
0.06
Earnings History > 18 > surprise Percent
15.3846
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-24
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-12.23
Earnings History > 19 > eps Estimate
-1.94
Earnings History > 19 > eps Difference
-10.29
Earnings History > 19 > surprise Percent
-530.4124
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-09-30
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.2096
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-06-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.1694
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-03-31
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.1163
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases. The company's lead product candidate consists of atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN). It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APatrick Enright Acquires 5,882 Shares of Vera Therapeutics (NASDAQ:VERA) Stock - MarketBeat
12/16/2025
Patrick Enright Acquires 5,882 Shares of Vera Therapeutics (NASDAQ:VERA) Stock MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$62.8462
Analyst Picks
Strong Buy
9
Buy
4
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 100.95% of the total shares of Vera Therapeutics Inc
1.
venBio Select Advisor LLC(9.8709%)
since
2025/06/30
2.
T. Rowe Price Associates, Inc.(7.0189%)
since
2025/06/30
3.
BlackRock Inc(6.5266%)
since
2025/06/30
4.
Kynam Capital Management, LP(5.3693%)
since
2025/06/30
5.
Deerfield Management Co(5.2459%)
since
2025/06/30
6.
Vestal Point Capital LP(4.8571%)
since
2025/06/30
7.
Vanguard Group Inc(4.7022%)
since
2025/06/30
8.
FMR Inc(4.5594%)
since
2025/06/30
9.
Sofinnova Ventures(4.3777%)
since
2025/06/30
10.
Woodline Partners LP(4.0868%)
since
2025/06/30
11.
Eversept Partners, LLC(3.7338%)
since
2025/06/30
12.
Morgan Stanley - Brokerage Accounts(3.5069%)
since
2025/06/30
13.
State Street Corp(3.1613%)
since
2025/06/30
14.
US Small-Cap Growth II Equity Comp(2.4455%)
since
2025/06/30
15.
Vanguard Total Stock Mkt Idx Inv(2.3552%)
since
2025/07/31
16.
TANG CAPITAL MANAGEMENT LLC(2.1152%)
since
2025/06/30
17.
Geode Capital Management, LLC(2.029%)
since
2025/06/30
18.
iShares Russell 2000 ETF(1.9366%)
since
2025/08/31
19.
Fidelity Growth Compy Commingled Pl S(1.8659%)
since
2025/07/31
20.
Integral Health Asset Management, LLC(1.8018%)
since
2025/06/30
21.
T. Rowe Price New Horizons(1.7379%)
since
2025/07/31
22.
Fidelity Growth Company Fund(1.3768%)
since
2025/07/31
23.
SPDR® S&P Biotech ETF(1.3757%)
since
2025/08/31
24.
T. Rowe Price Health Sciences(1.2645%)
since
2025/07/31
25.
COMMODORE CAPITAL LP(1.2535%)
since
2025/06/30
26.
Pictet Asset Manangement SA(1.2109%)
since
2025/06/30
27.
American Century Companies Inc(1.1194%)
since
2025/06/30
28.
International Biotechnology Ord(1.0578%)
since
2025/08/31
29.
Rock Springs Capital Management LP(0.9673%)
since
2025/06/30
30.
Vanguard Institutional Extnd Mkt Idx Tr(0.9326%)
since
2025/07/31
31.
American Century U.S. Small Cap Growth(0.8839%)
since
2025/06/30
32.
American Century Small Cap Growth Inv(0.8839%)
since
2025/06/30
33.
Fidelity Small Cap Index(0.8091%)
since
2025/06/30
34.
T. Rowe Price New Horizons Tr-A(0.7905%)
since
2025/06/30
35.
iShares Russell 2000 Growth ETF(0.7099%)
since
2025/08/31
36.
T. Rowe Price Integrated US Sm Gr Eq(0.6571%)
since
2025/07/31
37.
T. Rowe Price Integrated US SmCapGrEq(0.6571%)
since
2025/06/30
38.
Pictet-Biotech P USD(0.6125%)
since
2025/05/31
39.
Fidelity Select Biotechnology(0.6106%)
since
2025/07/31
40.
Xtrackers S&P 500 Swap ETF 1C(0.4747%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-1.3
Date
2025-09-30
EPS Actual
-1.26
EPS Estimate
-1.15
EPS Difference
-0.11
Surprise Percent
-9.5652%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.